Large liver cell dysplasia: A controversial entity

Journal of Hepatology

Volumn 45, Issue 5, 2006, Pages 734-743

  Park, Young Nyun ^a   Roncalli, Massimo ^b  

^a Yonsei University   (South Korea)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

Cirrhosis; Hepatocellular carcinoma; Large liver cell change; Large liver cell dysplasia

Indexed keywords

CYTOKERATIN; DNA; FERRITIN; GENE PRODUCT; HEPATITIS B SURFACE ANTIGEN; IRON; PROTEIN P53;

APOPTOSIS; CELL PROLIFERATION; CELL STRUCTURE; HUMAN; IMMUNOREACTIVITY; LARGE LIVER CELL DYSPLASIA; LIVER CARCINOGENESIS; LIVER DISEASE; MORBIDITY; NONHUMAN; PHENOTYPE; PLOIDY; PRIORITY JOURNAL; REVIEW;

ANIMALS; CARCINOMA, HEPATOCELLULAR; HEPATITIS, VIRAL, HUMAN; HEPATOCYTES; HUMANS; LIVER; LIVER CIRRHOSIS; LIVER NEOPLASMS; MICE; MICE, TRANSGENIC; MODELS, ANIMAL; PRECANCEROUS CONDITIONS; PREDICTIVE VALUE OF TESTS;

EID: 33749067406     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2006.08.002     Document Type: Review

References (58)

1. Anthony P.P., Vogel C.L., and Barker L.F. Liver cell dysplasia: a premalignant condition. J Clin Path 26 (1973) 217-223
2. Watanabe S., Okita K., Harada T., Kodama T., Numa Y., Takemoto T., et al. Morphologic studies of the liver cell dysplasia. Cancer 51 (1983) 2197-2205
3. International Working Party. Terminology of nodular hepatocellular lesions. Hepatology 1995;22:983-93.
4. Libbrecht L., Desmet V., and Roskams T. Preneoplastic lesions in human hepatocarcinogenesis. Liver Int 25 (2005) 16-27
5. Marchio A., Terris B., Meddeb M., Pineau P., Duverger A., Tiollais P., et al. Chromosomal abnormalities in liver cell dysplasia detected by comparative genomic hybridisation. Mol Pathol 54 (2001) 270-274
6. Roncalli M., Borzio M., Tombesi M.V., Ferrari A., and Servida E. A morphometric study of liver cell dysplasia. Hum Pathol 19 (1988) 471-474
7. Giannini A., Zampi G., Bartoloni F., and Omer S. Morphological precursors of hepatocellular carcinoma: a morphometrical analysis. Hepatogastroenterology 34 (1987) 95-97
8. Henmi A., Uchida T., and Shikata T. Karyometric analysis of liver cell dysplasia and hepatocellular carcinoma. Evidence against precancerous nature of liver cell dysplasia. Cancer 55 (1985) 2594-2599
9. Zhao M., Zhang N.X., Laissue J.A., and Zimmermann A. Immunohistochemical analysis of p53 protein overexpression in liver cell dysplasia and in hepatocellular carcinoma. Virchows Arch 424 (1994) 613-621
10. Borzio M., Bruno S., Roncalli M., Mels G.C., Ramella G., Borzio F., et al. Liver cell dysplasia is a major risk factor for hepatocellular carcinoma in cirrhosis: a prospective study. Gastroenterology 108 (1995) 812-817
11. Ganne-Carrie N., Chastang C., Chapel F., Munz C., Pateron D., Sibony M., et al. Predictive score for the development of hepatocellular carcinoma and additional value of liver large cell dysplasia in Western patients with cirrhosis. Hepatology 23 (1996) 1112-1118
12. Libbrecht L., Craninx M., Nevens F., Desmet V., and Roskams T. Predictive value of liver cell dysplasia for development of hepatocellular carcinoma in patients with non-cirrhotic and cirrhotic chronic viral hepatitis. Histopathology 39 (2001) 66-73
13. Serov V.V., and Beketora T.P. The morphological characteristics of hepatocyte dysplasia. Arkh Patol 52 (1990) 36-42
14. Lee R.G., Tsamandas A.C., and Demetris A.J. Large cell change (liver cell dysplasia) and hepatocellular carcinoma in cirrhosis: matched case-control study, pathological analysis, and pathogenetic hypothesis. Hepatology 26 (1997) 1415-1422
15. Roncalli M., Borzio M., De Biagi G., Ferrari A.R., Macchi R., Tombesi V.M., et al. Liver cell dysplasia in cirrhosis. A serologic and immunohistochemical study. Cancer 57 (1986) 1515-1521
16. Le Bail B., Bernard P.H., Carles J., Balabaud C., and Bioulac-Sage P. Prevalence of liver cell dysplasia and association with HCC in series of 100 cirrhotic liver explants. J Hepatol 27 (1997) 835-842
17. Hytrioglou P., Theise N.D., Schwartz M., Mor E., Miller C., and Thung S.N. Macroregenerative nodules in a series of adult cirrhotic liver explants: issues of classification and nomenclature. Hepatology 21 (1995) 703-708
18. Lefkowitch J.H., Schiff E.R., Davis G.L., Perrillo R.P., Lindsay K., Bodenheimer Jr. H.C., et al. Pathological diagnosis of chronic hepatitis C: a multicenter comparative study with chronic hepatitis B. Gastroenterology 104 (1993) 595-603
19. Ho J.C., Wu P.C., and Mak T.K. Liver cell dysplasia in association with hepatocellular carcinoma, cirrhosis and hepatitis B surface antigen in Hong Kong. Int J Cancer 28 (1981) 571-574
20. Shibata M., Morizane T., Uchida T., Yamagami T., Onozuka Y., Nakano M., et al. Irregular regeneration of hepatocytes and risk of hepatocellular carcinoma in chronic hepatitis and cirrhosis with hepatitis C-virus infection. Lancet 351 (1998) 1773-1777
21. Paterson A.C., Kew M.C., Duskeiko G.M., and Isaacson C. Liver cell dysplasia accompanying hepatocellular carcinoma in southern Africa. Differences between urban and rural populations. J Hepatol 8 (1989) 241-248
22. Fracanzani A.L., Borzio M., Roncalli M., Derenzini M., Trere D., Mattioli M., et al. Can large cell change and high proliferative activity predict hepatocellular carcinoma in patients with hereditary hemochromatosis?. Am J Gastroenterol 95 (2000) 2940-2945
23. Esquivel C.O., Gutierrez C., Cox K.L., Garcia-Kennedy R., Berquist W., and Concepcion W. Hepatocellular carcinoma and liver cell dysplasia in children with chronic liver disease. J Pediatr Surg 29 (1994) 1465-1469
24. Cohen C., and DeRose P.B. Liver cell dysplasia in alpha-1-antitrypsin deficiency. Mod Pathol 7 (1994) 31-36
25. Natarajan S., Theise N.D., Thung S.N., Antonio L., Paronetto F., and Hytiroglou P. Large-cell change of hepatocytes in cirrhosis may represent a reaction to prolonged cholestasis. Am J Surg Pathol 21 (1997) 312-318
26. Omata M., Mori J., Yokosuka O., Iwama S., Ito Y., and Okuda K. Hepatitis B virus antigens in liver tissue in hepatocellular carcinoma and advanced chronic liver disease-relationship to liver cell dysplasia. Liver 2 (1982) 125-132
27. Sakurai M. Liver cell dysplasia and hepatitis B surface and core antigens in cirrhosis and hepatocellular carcinoma of autopsy cases. Acta Pathol Jpn 28 (1978) 705-719
28. Kew M.C., Ray M.B., Desmet V.J., and Desmyter J. Hepatitis-B surface antigen in tumour tissue and non-tumorous liver in black patients with hepatocellular carcinoma. Br J Cancer 41 (1980) 399-406
29. Nakashima T., Okuda K., Kojiro M., Jimi A., Yamaguchi R., Sakamoto K., et al. Pathology of hepatocellular carcinoma in Japan. 232 Consecutive cases autopsied in ten years. Cancer 51 (1983) 863-877
30. Cohen C., and DeRose P.B. Immunohistochemical p53 in hepatocellular carcinoma and liver cell dysplasia. Mod Pathol 7 (1994) 536-539
31. D'Errico A., Grigioni W.F., Fiorentino M., Baccarini P., Grazi G.L., and Mancini A.M. Overexpression of p53 protein and Ki67 proliferative index in hepatocellular carcinoma: an immunohistochemical study on 109 Italian patients. Pathol Int 44 (1994) 682-687
32. Goldblum J.R., Bartos R.E., Carr K.A., and Frank T.S. Hepatitis B and alterations of the p53 tumor suppressor gene in hepatocellular carcinoma. Am J Surg Pathol 17 (1993) 1244-1251
33. Zhao M., and Zimmermann A. Liver cell dysplasia: reactivities for c-met protein, Rb protein, E-cadherin and transforming growth factor-beta 1 in comparison with hepatocellular carcinoma. Histol Histopathol 13 (1998) 657-670
34. Zhao M., Zhang N.X., Economou M., Blaha I., Laissue J.A., and Zimmermann A. Immunohistochemical detection of bcl-2 protein in liver lesions: bcl-2 protein is expressed in hepatocellular carcinomas but not in liver cell dysplasia. Histopathology 25 (1994) 237-245
35. Roncalli M., Borzio M., de Biagi G., Servida E., Cantaboni A., Sironi M., et al. Liver cell dysplasia and hepatocellular carcinoma: a histological and immunohistochemical study. Histopathology 9 (1985) 209-221
36. Libbrecht L., Desmet V., Van Damme B., and Roskams T. The immunohistochemical phenotype of dysplastic foci in human liver: correlation with putative progenitor cells. J Hepatol 33 (2000) 76-84
37. Koo J.S., Seong J.K., Park C., Yu D.Y., Oh B.K., Oh S.H., et al. Large liver cell dysplasia in hepatitis B virus X transgenic mouse liver and human chronic hepatitis B virus-infected liver. Intervirology 48 (2005) 16-22
38. Roncalli M., Borzio M., Brando B., Colloredo G., and Servida E. Abnormal DNA content in liver-cell dysplasia: a flow cytometric study. Int J Cancer 44 (1989) 204-207
39. Thomas R.M., Berman J.J., Yetter R.A., Moore G.W., and Hutchins G.M. Liver cell dysplasia: a DNA aneuploid lesion with distinct morphologic features. Hum Pathol 23 (1992) 496-503
40. Orsatti G., Theise N.D., Thung S.N., and Paronetto F. DNA image cytometric analysis of macroregenerative nodules (adenomatous hyperplasia) of the liver: evidence in support of their preneoplastic nature. Hepatology 17 (1993) 621-627
41. Rubin E.M., DeRose P.B., and Cohen C. Comparative image cytometric DNA ploidy of liver cell dysplasia and hepatocellular carcinoma. Mod Pathol 7 (1994) 677-680
42. El-Sayed S.S., El-Sadany M., Tabll A.A., Soltan A., El-Dosoky I., and Attallah A.M. DNA ploidy and liver cell dysplasia in liver biopsies from patients with liver cirrhosis. Can J Gastroenterol 18 (2004) 87-91
43. Terris B., Ingster O., Rubbia L., Dubois S., Belghiti J., Feldmann G., et al. Interphase cytogenetic analysis reveals numerical chromosome aberrations in large liver cell dysplasia. J Hepatol 27 (1997) 313-319
44. Zondervan P.E., Wink J., Alers J.C., IJzermans J.N., Schalm S.W., de Man R.A., et al. Molecular cytogenetic evaluation of virus-associated and non-viral hepatocellular carcinoma: analysis of 26 carcinomas and 12 concurrent dysplasias. J Pathol 192 (2000) 207-215
45. Paradis V., Laurendeau I., Vidaud M., and Bedossa P. Clonal analysis of macronodules in cirrhosis. Hepatology 28 (1998) 953-958
46. Rabinovitch P.S., Dziadon S., Brentnall T.A., Emond M.J., Crispin D.A., Haggitt R.C., et al. Pancolonic chromosomal instability precedes dysplasia and cancer in ulcerative colitis. Cancer Res 59 (1999) 5148-5153
47. Hermsen M., Postma C., Baak J., Weiss M., Rapallo A., Sciutto A., et al. Colorectal adenoma to carcinoma progression follows multiple pathways of chromosomal instability. Gastroenterology 123 (2002) 1109-1119
48. Donato M.F., Arosio E., Del Ninno E., Ronchi G., Lampertico P., Morabito A., et al. High rates of hepatocellular carcinoma in cirrhotic patients with high liver cell proliferative activity. Hepatology 34 (2001) 523-528
49. Borzio M., Fargion S., Borzio F., Fracanzani A.L., Croce A.M., Stroffolini T., et al. Impact of large regenerative, low grade and high grade dysplastic nodules in hepatocellular carcinoma development. J Hepatol 39 (2003) 208-214
50. Santoni-Rugiu E., Nagy P., Jensen M.R., Factor V.M., and Thorgeirsson S.S. Evolution of neoplastic development in the liver of transgenic mice co-expressing c-myc and transforming growth factor-alpha. Am J Pathol 149 (1996) 407-428
51. Deane N.G., Parker M.A., Aramandla R., Diehl L., Lee W.J., Washington M.K., et al. Hepatocellular carcinoma results from chronic cyclin D1 overexpression in transgenic mice. Cancer Res 61 (2001) 5389-5395
52. Harada N., Oshima H., Katoh M., Tamai Y., Oshima M., and Taketo M.M. Hepatocarcinogenesis in mice with beta-catenin and Ha-ras gene mutations. Cancer Res 64 (2004) 48-54
53. Yu D.Y., Moon H.B., Son J.K., Jeong S., Yu S.L., Yoon H., et al. Incidence of hepatocellular carcinoma in transgenic mice expressing the hepatitis B virus X-protein. J Hepatol 31 (1999) 123-132
54. Lee G.H., Merlino G., and Fausto N. Development of liver tumors in transforming growth factor alpha transgenic mice. Cancer Res 52 (1992) 5162-5170
55. Schirmacher P., Held W.A., Yang D., Biempica L., and Rogler C.E. Selective ampilification of periportal transitional cells precedes formation of hepatocellular carcinoma in SV40 large tag transgenic mice. Am J Pathol 139 (1991) 231-241
56. Sargent L.M., Sanderson N.D., and Thorgeirsson S.S. Ploidy and karyotypic alterations associated with early events in the development of hepatocarcinogenesis in transgenic mice harboring c-myc and transforming growth factor alpha transgenes. Cancer Res 56 (1996) 2137-2142
57. Webber E.M., Wu J.C., Wang L., Merlino G., and Fausto N. Overexpression of transforming growth factor-α causes liver enlargement and increased hepatocyte proliferation in transgenic mice. Am J Pathol 145 (1994) 398-408
58. Lakhtakia R., Kumar V., Reddi H., Mathur M., Dattagupta S., and Panda S.K. Hepatocellular carcinoma in a hepatitis B 'x' transgenic mouse model: a sequential pathological evaluation. J Gastroenterol Hepatol 18 (2003) 80-91